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Background: Epicardial adipose tissue (EAT) is the ectopic visceral fat surrounding the heart, which plays an
important role in atherosclerosis of the coronary arteries via endothelial damage. Several studies have also sug-
gested that vasospasmwith angina (VSA) causes endothelial dysfunction in the coronary arteries. The aim of this
study was to evaluate the thickness of EAT in the anterior interventricular groove (EAT-AIG) using echocardiog-
raphy in patients who had no obstructive coronary artery disease and were suspected of having VSA.Methods: Sixty-five patients who underwent intracoronary acetylcholine provocation testing for clinical
indications were prospectively enrolled. VSA was diagnosed by coronary artery stenosis increase of >90%
and the presentation of chest pain with ischemic changes on electrocardiography.Results: Subjects were divided into two groups, with and without significant coronary spasm (VSA group, 30
patients; non-VSA group, 35 patients), consistent with acetylcholine provocation testing. EAT-AIG thickness
was significantly greater in the VSA group than in the non-VSA group (8.26 2.7 vs 6.16 2.5 mm, P = .002). By
receiver operating characteristic analysis, EAT-AIG thickness had a high C statistic (area under the
curve = 0.81, P < .001) after adjustment for conventional risk factors (smoking, diabetes mellitus, and dyslipi-
demia). EAT-AIG thickness had incremental diagnostic value over other conventional risk factors (area under
the curve = 0.81 vs 0.64, P for comparison = .020).Conclusions: EAT-AIG thickness, which is noninvasively and easily measured using transthoracic echo-
cardiography, can be one of multiple clinical variables associated with VSA. (J Am Soc Echocardiogr
2017;30:1021-7.)
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interventricular groovePrevious studies have shown that increased epicardial adipose tissue
(EAT) thickness is associated with known cardiovascular risk factors.1
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rg/10.1016/j.echo.2017.06.024and has some advantages over other methods (i.e., it is noninvasive,
relatively economical, and easy to perform for screening).
Echocardiographic EAT thickness has been defined as the thickness
of the low-isoechoic area on the free wall of the right ventricle (RV)
in the parasternal long- and short-axis views.2 EAT is not uniformly
distributed, as adipose tissue concentrates primarily in the interven-
tricular and atrioventricular grooves rather than in nongroove seg-
ments, such as the free wall of the RV.3 We recently reported that
the echocardiographic thickness of EAT in the anterior interventric-
ular groove (EAT-AIG), obtained using a higher frequency linear
probe, was well correlated with EAT volume measured by computed
tomography and associated with coronary artery disease (CAD).4
Vasospasm with angina (VSA) is caused by focal or diffuse
spasm of a major coronary artery, resulting in a high-grade
obstruction.5,6 Although it is sometimes thought that patients
with VSA have relatively favorable outcomes, their clinical
outcomes strongly depend on early diagnosis. Because the
treatment strategies for VSA and other chest pain or
discomfort diseases are substantially different, it is important to1021
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October 2017distinguish VSA. Recent
studies have suggested that
EAT has been associated with
many manifestations of
vasoconstrictor-vasodilator im-
balance and impaired coronary
vasomotion.7 However, the
relationship between EAT and
VSA is not well established.
We hypothesized that echocar-
diographic EAT-AIG thickness
can be a marker for the detec-
tion of VSA in patients without
obstructive coronary artery dis-
ease. Our study aim was to
assess the utility of EAT-AIG
thickness by echocardiography
in differentiating between pa-
tients with and without VSA.METHODSStudy Population
We consecutively enrolled 792 patients who underwent their first cor-
onary angiographic examinations from May 1, 2012, to November 1,
2014, at Tokushima University Hospital. In the present study, the
analyzed population was patients who had no significant coronary artery
stenosis but were suspected to have VSA (chest pain or chest discomfort
at rest). Therefore, patients who demonstrated$50% stenosis on coro-
nary angiography (n = 482) or lacked typical VSA symptoms (n = 212)
were excluded. Subjects were also excluded if they refused to undergo
the intracoronary acetylcholine (ACh) stress test (n=33). After these ex-
clusions, 65 patients remained for the final analysis (Figure 1). Theywere
scheduled to undergo intracoronary ACh stress testing to diagnosis VSA.
We also enrolled 30 age- and gender-matched healthy control subjects
who were selected from our healthy volunteer database on the basis
of a comprehensive history and physical examination, to determine
the normal value of EAT. The study was approved by the institutional re-
view board of Tokushima University Hospital (no. 2183-1), and written
informed consent was obtained from all subjects.
All subjects were classified into either the VSA group or the non-VSA
group. The VSA groupwas defined as patients who had coronary spasm
in any coronary artery during the intracoronary ACh stress test.
Hypertension was defined as systolic blood pressure > 140 mm Hg
and/or diastolic blood pressure > 90 mm Hg or current treatment
with antihypertensive medication. Diabetes mellitus was defined as fast-
ing blood glucose 126mg/dL, glycated hemoglobin$ 6.5%, and/or the
need for oral hypoglycemic agents. Dyslipidemia was defined as plasma
total cholesterol > 220 mg/dL or the use of lipid-lowering therapy.
Smoking was defined as current or previous use of cigarettes.Echocardiographic Examination
Echocardiography was performed using commercially available ul-
trasound machines (Vivid E9 [GE Healthcare, Milwaukee, WI], iE33
[Philips Healthcare, Best, The Netherlands]; Aplio 500 [Toshiba
Medical Systems, Tochigi, Japan]; or a10, Preirus [Hitachi, Tokyo,
Japan]) 1 day before coronary angiography. The details of EAT thick-
ness measurements have already been described in our previousreport.4 Using a high-frequency linear probe (7.5–11 MHz), EAT thick-
ness was measured at end-systole in two locations: in the AIG, where
the left anterior descending coronary artery (LAD) runs, and on the
freewall of the RV, away fromanymajor epicardial artery.While assess-
ing EAT-AIG thickness, we searched for the distal portion of the LAD
and carefully rotated the probe until a longitudinal section was identi-
fied. EAT-AIG thickness was measured as the distance from the outer
wall of the myocardium to the visceral layer of the epicardium. EAT-
RV thickness was measured using the method previously reported
by Iacobellis and Willens.8 The thickness of pericardial adipose tissue
over the free wall of the RV outside of the parietal pericardium was
also measured at end-systole from the same image used to measure
EAT-RV thickness.Measurementswere performed during three cardiac
cycles for each parameter, and the mean for each parameter was used
for analysis. The reproducibility of EAT-AIG thickness, expressed as the
intraclass correlation coefficient, has been described in detail by our
group as 0.98 and 0.91 for intraobserver and interobserver variation.4Provocation Testing of VSA
The intracoronary infusion of ACh was performed according to the
guidelines for diagnosis and treatment of patients with vasospastic
angina.9 The administration of vasoactive drugs, including calcium
channel blockers, nitrates, b-adrenergic blockers, and other vasodilators,
was stopped for$2 days before angiography. Before performing vaso-
spasm provocation testing with ACh, controlled coronary angiography
was performed. AChwas injected from the same angle over a period of
20 sec into the right coronary artery (RCA; at a dose of 20 or 50mg) and
the left coronary artery (LCA; at a dose of 20, 50, or 100 mg) according
to the clinical condition. Angiography was subsequently performed
1 min after the start of each injection. Angiography was also performed
after presentation of ischemic changes on electrocardiography or chest
pain. Coronary spasmwas defined as total or subtotal occlusion ($90%
stenosis) accompanied by episodes of chest pain or ischemic ST-
segment changes on electrocardiography (Figure 2).Statistical Analysis
Data are presented as mean 6 SD. Student’s t test was used to
compare continuous variables between the two groups (VSA and
non-VSA). When comparing between three groups (VSA, non-VSA,
and normal), we added the control group to use the analysis of variance
with the Bonferroni method. Logistic regression was used to calculate
odds ratios and 95% CIs after adjustment for potential confounders.
Potential confounders, such as smoking, diabetes mellitus, and dyslipide-
mia, were entered in multivariate models. The performance of clinical
risk factors (smoking, diabetes mellitus, and dyslipidemia) plus various
combinations of EAT-AIG thickness was assessed using the area under
the curve in receiver operating characteristic analysis. To evaluate the
correlation of EAT-AIG thickness and presence of VSA, two models
were constructed and compared using receiver operating characteristic
analysis. Model 1, the basic model, consisted of clinical risk factors alone.
Model 2 included the variables in model 1 plus EAT-AIG thickness. The
DeLong method was used to compare the C statistic.10 We conducted
bootstrapping with 2,000 resamples to assess the internal validation.
Statistical analysis was performed using standard statistical software
packages (SPSS version 21.0 [SPSS, Chicago, IL], MedCalc version
15.8 [MedCalc Software, Mariakerke, Belgium], and R version 3.3.3
[R Foundation for StatisticalComputing,Vienna,Austria]).P values< .05
were considered to indicate statistical significance.
?Figure 1 Flowchart of the recruitment of patients.
Figure 2 Representative recordings. VSA group: a 73-year-old woman presented with chest discomfort. EAT was thickened, and we
suspected coronary artery disease or VSA. Coronary angiography revealed that there was no significant organic stenosis. We added
ACh provocation testing. Significant coronary spasm was observed, and we diagnosed VSA. Non-VSA group: an 87-year-old man
presented with chest discomfort. EAT was not thickened. The coronary artery had no significant stenosis, and ACh provocation
testing was negative. PAT, Pericardial adipose tissue.
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Table 1 Clinical background
Healthy control (n = 30) VSA (n = 30) Non-VSA (n = 35) P value for VSA vs non-VSA
Age (y) 65 6 10 66 6 9 65 6 12 .705
Men/women 17/13 19/11 18/17 .218
Height (cm) 161 6 8 160 6 10 159 6 10 .698
Weight (kg) 61 6 12 60 6 10 60 6 13 .815
Heart rate (beats/min) 66 6 11 66 6 14 66 6 12 .896
BMI (kg/m2) 23 6 4 23 6 2 24 6 3 .578
Systolic blood pressure (mm Hg) 127 6 15 130 6 16 131 6 22 .797
Diastolic blood pressure (mm Hg) 75 6 8 74 6 13 72 6 13 .431
Risk factors
Diabetes mellitus — 8 (27%) 5 (14%) .229
Hypertension — 16 (53%) 18 (51%) .881
Dyslipidemia — 14 (47%) 12 (34%) .319
Smoking — 17 (57%) 12 (34%) .073
Medication
Diabetes mellitus drug — 5 (17%) 2 (5%) .178
Calcium channel blocker — 9 (30%) 17 (49%) .129
Statins — 12 (32%) 9 (26%) .231
Laboratory data
HDL cholesterol (mg/dL) — 60 6 18 61 6 15 .856
LDL cholesterol (mg/dL) — 111 6 33 113 6 32 .826
LDL/HDL — 2.0 6 0.7 2.0 6 0.8 .985
AA (mg/mL) — 203 6 54 182 6 46 .122
DHA (mg/mL) — 163 6 69 161 6 69 .924
DHLA (mg/mL) — 41 6 12 37 6 13 .230
EPA (mg/mL) — 65 6 35 82 6 57 .168
EPA/AA — 0.34 6 0.19 0.49 6 0.38 .073
CRP (mg/dL) — 0.07 6 0.05 0.08 6 0.16 .737
Creatinine (mg/dL) — 0.78 6 0.16 0.73 6 0.24 .284
Glycated hemoglobin (%) — 5.9 6 0.7 5.9 6 0.9 .661
BNP (pg/mL) — 42 6 51 35 6 38 .544
AA, Arachidonic acid; BMI, body mass index; BNP, B-type natriuretic peptide; CRP, C-reactive protein; DHA, docosahexaenoic acid; DHLA,
dihomo-gamma-linolenic acid; EPA, eicosapentaenoic acid; HDL, high-density lipoprotein; LDL, low-density lipoprotein.
Data are expressed as mean 6 SD or as number (percentage).
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Patient Characteristics
On the basis of the results of ACh provocation testing, subjects were
divided into two groups with (VSA group: 30 patients; mean age,
66 6 9 years; 19 men) and without (non-VSA group: 35 patients;
mean age, 65 6 12 years; 18 men) significant coronary spasm. We
added age-matched healthy control subjects (control group: 30 pa-
tients; mean age, 65610 years; 17 men) in the analysis. Clinical char-
acteristics of the patients in the VSA group, non-VSA group, and
control group are presented in Table 1. There were no significant dif-
ferences in age, gender, body mass index, and blood pressure among
all three groups. Neither were there any differences in cardiovascular
risk factors between the VSA and non-VSA groups. In the non-VSA
group, all patients underwent provocative testing with ACh 50 mg
in the RCA and ACh 100 mg in the LCA. In the VSA group, for the
provocative test in the RCA, two subjects received ACh 20 mg and
22 subjects ACh 50 mg. For the provocative test in the LCA, no sub-
jects received ACh 20 mg, three received ACh 50 mg, and 17 receivedACh 100 mg. Thus, many patients underwent provocative testing with
the maximum dose of ACh.Echocardiographic Parameters andMeasurements of EAT
Thickness
Wewere able to measure EAT thicknesses using echocardiography in all
subjects. Echocardiographic parameters and measurements of EAT
thicknesses are presented in Table 2. There were no significant differ-
ences in left ventricular and left atrial size andDoppler findings between
the VSA and non-VSA groups. EAT-AIG thickness was significantly
greater in the VSA group than in the non-VSA group (8.2 6 2.7 vs
6.1 6 2.5 mm, P = .002). Interestingly, there was no difference of
EAT-AIG thickness between the control and non-VSA groups.
No differences in EAT-AIG thickness were found between patients
with no visible stenosis (0% stenosis, n = 50) and those with mild ste-
nosis (1%–49% stenosis, n = 15; 7.2 6 2.9 vs 6.9 6 2.2 mm,
P = .733). The prevalence of VSAwas similar in both of these groups
(42% vs 60%, P = .119). Furthermore, in the non-VSA group, there
Table 2 Echocardiographic examination result
Healthy control (n = 30) VSA (n = 30) Non-VSA (n = 35) P value for VSA vs non-VSA
LV and LA size
LV EDV (mL) 86 6 22 82 6 24 81 6 18 .871
LV ESV (mL) 30 6 9 29 6 9 28 6 8 .576
LV mass index (g/m2) 82 6 16 83 6 19 80 6 23 .654
LA volume index (ml/m2) 29 6 9 27 6 7 29 6 8 .302
LV ejection fraction (%) 66 6 6 65 6 5 66 6 5 .389
Doppler findings
E (cm/sec) 61 6 13 60 6 20 63 6 13 .430
DT (msec) 228 6 38 240 6 69 239 6 60 .927
A (cm/sec) 71 6 18 70 6 13 76 6 23 .193
E/A ratio 0.89 6 0.23 0.89 6 0.39 0.91 6 0.35 .860
Lateral s0 (cm/sec) 8.3 6 3.0 8.8 6 3.0 8.1 6 2.6 .334
Lateral e0 (cm/sec) 9.5 6 2.4 8.5 6 2.3 9.6 6 2.5 .089
Lateral a0 (cm/sec) 10.1 6 2.4 11.2 6 3.2 10.3 6 2.6 .958
E/e0 ratio 7.1 6 2.7 7.5 6 3.3 7.0 6 2.4 .491
Adipose tissue thickness
EAT-AIG thickness (mm) 6.1 6 2.4 8.2 6 2.7* 6.1 6 2.5 .002
EAT-RV thickness (mm) 4.0 6 2.3 4.6 6 2.0 4.5 6 1.8 .822
PAT thickness (mm) 4.3 6 2.4 5.0 6 2.0 4.5 6 2.7 .388
DT,Deceleration timeofEwave;EDV, end-diastolic volume;ESV, end-systolicvolume;LA, left atrial;LV, left ventricular;PAT, pericardial adipose tissue.
Data are expressed as mean 6 SD.
*P < .05 versus control group.
Table 3 Logistic regression analysis for VSA after
adjustment for smoking, diabetes mellitus, and dyslipidemia
c2 Odds ratio 95% CI P value
e0 (cm/sec) 8.639 0.8140 0.6473–1.0236 .071
EAT-AIG
thickness (mm)
19.658 1.5481 1.1896–2.0147 .001
EAT-RV
thickness (mm)
6.395 1.1425 0.8304–1.5720 .375
PAT thickness (mm) 7.745 1.0403 0.8135–1.3304 .717
PAT, Pericardial adipose tissue.
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and 20 patients with no visible stenosis after ACh infusion. In the 15
patients with mild LAD stenosis after ACh infusion, there was a weak
trend between the percentage of stenosis at LAD and EAT-AIG thick-
ness (Supplemental Figure 1, available at www.onlinejase.com).
Given these results, abnormal response with coronary stenosis may
be associated with EAT-AIG thickness.
To determine the associated variables of VSA, we performed multi-
variate analysis of the association between baseline clinical and echocar-
diographic variables and VSA presence. The multivariate analysis for
classification of VSA is presented in Table 3. After adjustment for smok-
ing, diabetesmellitus, anddyslipidemia, EAT-AIG thicknesswas found to
be significantly associated with VSA (c2 = 19.66; odds ratio, 1.55; 95%
CI, 1.19–2.01; P = .001). EAT-AIG thickness had the highest C-statistic
(0.73;P= .007) among adipose tissue thicknesses. By receiver operating
characteristic curve analysis, EAT-AIG thickness > 6.9mmwas linked to
the presence of significantVSAwith 70%sensitivity and71%specificity.
EAT-AIG thickness showedahigh areaunder the curve after adjustment
for clinical variables (0.81;95%CI, 0.70–0.91;P< .001). EAT-AIG thick-
ness had incremental diagnostic value over other conventional risk
factors (C statistic = 0.81 vs 0.64, P= .020; Figure 3).We assessed inter-
nal validationusing thebootstrapmethod.We found that thedifferences
inC statistics were similar between the original model and themodified
model developed using the bootstrap method with 2,000 simulations
(P = .020 for the original model, P = .019 for the bootstrap model).DISCUSSION
We sought to assess the correlation between EAT thickness, obtained
via noninvasive echocardiography using a high-frequency linearprobe, and VSA diagnosed using coronary angiography. Our study
brings new insights to the understanding of VSA: (1) there were no
significant differences in conventional echocardiographic findings
between patients in the VSA and non-VSA groups, (2) there was a
significant difference in EAT-AIG thickness between the VSA and
non-VSA groups, and (3) EAT-AIG thickness had incremental diag-
nostic value over other conventional risk factors (area under the
curve = 0.81 vs 0.64, P for comparison = .020). Therefore, we suggest
that increased EAT-AIG thickness was well correlated with the pres-
ence of VSA.Correlates of VSA
More than 55 years ago, the first report of VSA as a clinical disease
described episodes of rest angina that promptly respond to short-
acting nitrates.11 There is a regional difference and a racial difference
in the incidence rate of CAD. Generally, the incidence of CAD is
higher in Europeans and Americans than Asians, including
Sensitivity
Specificity
1.0
0.8
0.6
0.4
0.2
0
00.20.40.60.81.0
Model 1: AUC=0.64; 
95%CI:0.51-0.78
Model 2: AUC=0.81; 
95%CI:0.70-0.91
Model 1 vs. Model 2
Comparison P value=.020
Figure 3 Receiver operating characteristic analysis of EAT-AIG
measured using echocardiography for classifying VSA. Model 1
(clinical risk factors alone) and model 2 (model 1 plus EAT-AIG
thickness) were constructed and compared using receiver oper-
ating characteristic analysis. AUC, Area under the curve.
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October 2017Japanese.12 However, Japan has a higher prevalence of VSA compared
withWestern countries. VSA is thought to be involved in the pathogen-
esis of acute coronary syndromes.13 The prognosis of VSA has been
generally benign. However, coronary spasms frequently result in acute
myocardial infarction and sudden death.14,15 Clinical risk factors for
VSA, including smoking, alcohol use, diabetes mellitus, and
dyslipidemia, are well known.15-17 However, correlates of VSA have
not been well established. From our data, EAT-AIG is found to be
thicker in VSA. It might be a correlate of VSA with chest pain and
without organic coronary artery stenosis.Mechanism of Relationship between VSA and EAT
Many investigators have shown that excessive EAT can be amarker of
the presence and severity of CAD.18-21 Furthermore, we reported that
echocardiographic EAT-AIG thickness was greater in patients with
CAD.4 In previous studies, EAT is described as an organ involved in
the production of several inflammatory cytokines (e.g., interleukin-
1b, interleukin-6, monocyte chemotactic protein–1, tumor necrosis
factor–a).22-25 Inflammatory cytokines produced by infiltrating
macrophages or by adipocytes are thought to locally contribute to
the pathogenesis of coronary atherosclerosis.26,27 A recent study
showed that inflammatory mediators released from EAT augmented
coronary vasoconstriction.7 Another report suggested that EAT and
vasa vasorum had been thought to be a source of inflammation.22
Indeed, enhanced EAT inflammation has been shown to promote
progression of atherosclerosis.28 These results can support our result
that EAT-AIG thickness is a marker of inflammation surrounding cor-
onary arteries. Although the primary role of EAT is the secretion of
cardioprotective adipokines such as adiponectine,29 excessive accu-
mulation of EAT induces inflammation, leading to endothelium
dysfunction in a coronary artery. In laboratory markers, there is a
borderline difference in eicosapentaenoic acid/arachidonic acid ratio
between the presence and absence of VSA (Figure 1; P = .07). Thisresult also supported our hypothesis, because the level of the
eicosapentaenoic acid/arachidonic acid ratio has been well known
as a marker of atherosclerosis.30Echocardiographic Measurement of EAT Thickness
Echocardiographic EAT measurement is a noninvasive and simple way
to gauge location-specific EAT thickness. As first proposed by Iacobellis
et al.,2 EAT ismeasured at the right ventricular freewall in theparasternal
long- and short-axis views. However, the distribution of EAT-RV is not
uniform, and there are no coronary vessels in the right ventricular free
wall. Recent evidence has suggested that location-specific EAT thickness
at the groovewas closely associatedwith CAD.31 In our previous study,
we reported thatmeasurement of EAT-AIG thickness by echocardiogra-
phy, using a high-frequency linear probe, could be measured in 311 of
318 patients (98%).4 EAT-AIG thickness was highly correlatedwith EAT
volume compared with EAT-RV thickness. In addition, EAT-AIG thick-
ness has an additional and stronger prognostic value over EAT-RV thick-
ness in the prediction of coronary artery lesions. Thus, we believed that
measurement of EAT-AIG thickness can be useful in the clinical setting.Location of EAT Thickness
The mechanism of vasospasm with the location of EAT is a matter of
debate. A separate analysis examining LAD vasospasm alone related
to EAT-AIGwould be of great interest to this matter. In our cohort, there
some patients lacked infusion of ACh into both the left and right coro-
nary systems. When one coronary artery was positive, provoking vaso-
spasm in the other artery was thought to be unnecessary in the clinical
setting. Thus, for the analysis of LAD vasospasm alone, we excluded pa-
tients lacking of infusion into both coronary arteries. In patients with
infusion into both coronaries, there were nine patients with LCA vaso-
spasm alone, six patients with both LCA and RCAvasospasm, and two
patients with RCAvasospasm alone. In these groups, EAT-AIG thickness
was greater in three groups than in the non-VSA group (EAT-AIG: 6.1 vs
7.9 vs 8.2 vs 8.3 mm). Unfortunately, because of the limited number of
patients, we were unable to determine the relationship between EAT
location and coronary territory (Supplemental Figure 2, available at
www.onlinejase.com). On the other hand, in previous studies, perivas-
cular adipose tissue volume around the LADwas reported to be related
only to LAD vasospasm.32 Thus, EAT may be mechanistically linked to
coronary vasospasm by production of inflammatorymediators released
in proximity to the coronary arteries. To prove this hypothesis, further
echocardiographic studies involving patients with LAD spasm alone
are needed.Clinical Implications
To the best of our knowledge, this is the first report of echocardio-
graphic EAT-AIG thickness to help differentiate VSA with chest pain
or discomfort. However, the accuracy of 70% is relatively low. EAT-
AIG thickness is not sufficient enough to exclude VSA. This knowl-
edge may be useful as a risk factor and for follow-up of patients
with presumptive VSA. In addition, the results should be tested on
a large cohort of patients with presumptive VSA using EAT-AIG thick-
ness or EAT volume obtained from other cardiovascular imaging mo-
dalities (e.g., cardiac magnetic resonance imaging).Limitations
The design of this clinical study was cross-sectional, and it was conduct-
ed at a single center with a relatively small number of subjects. The study
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this study to patients of other ethnic backgrounds awaits further
research.Moreover, we enrolled only high-risk patients with vasospasm,
so the results of the present study may not be extrapolated to the gen-
eral population. We did not conduct studies of inflammatory markers to
assess the relationship between EATandVSA. Finally, the cutoff value of
EAT-AIG (6.9 mm) needs further validation in future studies.CONCLUSIONS
EAT-AIG thickness is noninvasively and easily measured using trans-
thoracic echocardiography and can be one of multiple clinical vari-
ables associated with VSA.ACKNOWLEDGMENT
We thank Robert Zheng, MD, for his work editing the manuscript.SUPPLEMENTARY DATA
Supplementary data related to this article can be found at http://dx.
doi.org/10.1016/j.echo.2017.06.024.REFERENCES
1. Mahabadi AA, Massaro JM, Rosito GA, Levy D, Murabito JM, Wolf PA,
et al. Association of pericardial fat, intrathoracic fat, and visceral abdominal
fat with cardiovascular disease burden: the Framingham Heart Study. Eur
Heart J 2009;30:850-6.
2. Iacobellis G, Assael F, RibaudoMC, Zappaterreno A, Alessi G, DiMario U,
et al. Epicardial fat from echocardiography: a new method for visceral ad-
ipose tissue prediction. Obesity Res 2003;11:304-10.
3. de Vos AM, Prokop M, Roos CJ, Meijs MF, van der Schouw YT, Rutten A,
et al. Peri-coronary epicardial adipose tissue is related to cardiovascular risk
factors and coronary artery calcification in post-menopausal women. Eur
Heart J 2008;29:777-83.
4. Hirata Y, Yamada H, Kusunose K, Iwase T, Nishio S, Hayashi S, et al. Clin-
ical utility of measuring epicardial adipose tissue thickness with echocardi-
ography using a high-frequency linear probe in patients with coronary
artery disease. J Am Soc Echocardiogr 2015;28:1240-6.
5. Kaski JC, Crea F, Meran D, Rodriguez L, Araujo L, Chierchia S, et al. Local
coronary supersensitivity to diverse vasoconstrictive stimuli in patients
with variant angina. Circulation 1986;74:1255-65.
6. Kaski JC, Maseri A, Vejar M, Crea F, Hackett D. Spontaneous coronary ar-
tery spasm in variant angina is caused by a local hyperreactivity to a gener-
alized constrictor stimulus. J Am Coll Cardiol 1989;14:1456-63.
7. Owen MK,Witzmann FA, McKenney ML, Lai X, Berwick ZC, Moberly SP,
et al. Perivascular adipose tissue potentiates contraction of coronary vascular
smooth muscle: influence of obesity. Circulation 2013;128:9-18.
8. Iacobellis G, Willens HJ. Echocardiographic epicardial fat: a review of
research and clinical applications. J Am Soc Echocardiogr 2009;22:1311-9.
9. JCS Joint Work Group. Guidelines for diagnosis and treatment of patients
with vasospastic angina (Coronary Spastic Angina) (JCS 2013). Circ J
2014;78:2779-801.
10. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas un-
der two or more correlated receiver operating characteristic curves: a
nonparametric approach. Biometrics 1988;44:837-45.
11. Prinzmetal M, Kennamer R, Merliss R, Wada T, Bor N. Angina pectoris. I. A
variant form of angina pectoris; preliminary report. Am J Med 1959;27:
375-88.12. Steg PG, Bhatt DL, Wilson PW, D’Agostino R Sr., Ohman EM, Rother J,
et al. One-year cardiovascular event rates in outpatients with atherothrom-
bosis. JAMA 2007;297:1197-206.
13. Ong P, Athanasiadis A, Borgulya G, Voehringer M, Sechtem U. 3-year
follow-up of patients with coronary artery spasm as cause of acute coronary
syndrome: theCASPAR (CoronaryArtery Spasm in PatientsWithAcuteCor-
onary Syndrome) study follow-up. J Am Coll Cardiol 2011;57:147-52.
14. Nakamura M, Takeshita A, Nose Y. Clinical characteristics associated with
myocardial infarction, arrhythmias, and sudden death in patients with
vasospastic angina. Circulation 1987;75:1110-6.
15. Yasue H, Takizawa A, Nagao M, Nishida S, Horie M, Kubota J, et al. Long-
term prognosis for patients with variant angina and influential factors. Cir-
culation 1988;78:1-9.
16. Shimabukuro M, Shinzato T, Higa S, Chibana T, Yoshida H, Nagamine F,
et al. Enhanced insulin response relates to acetylcholine-induced vasocon-
striction in vasospastic angina. J Am Coll Cardiol 1995;25:356-61.
17. Miwa K, Fujita M,Miyagi Y, Inoue H, Sasayama S. High-density lipoprotein
cholesterol level and smoking modify the prognosis of patients with coro-
nary vasospasm. Clin Cardiol 1995;18:267-72.
18. Shimabukuro M, Hirata Y, Tabata M, Dagvasumberel M, Sato H,
Kurobe H, et al. Epicardial adipose tissue volume and adipocytokine
imbalance are strongly linked to human coronary atherosclerosis. Arterios-
cler Thromb Vasc Biol 2013;33:1077-84.
19. Silaghi A, Piercecchi-Marti MD, Grino M, Leonetti G, Alessi MC,
Clement K, et al. Epicardial adipose tissue extent: relationship with age,
body fat distribution, and coronaropathy. Obesity 2008;16:2424-30.
20. Eroglu S, Sade LE, Yildirir A, Bal U, Ozbicer S, Ozgul AS, et al. Epicardial adi-
pose tissue thickness by echocardiography is a marker for the presence and
severityof coronary artery disease.NutrMetabCardiovascDis 2009;19:211-7.
21. Kim SH, Chung JH, Kwon BJ, Song SW, Choi WS. The associations of
epicardial adipose tissue with coronary artery disease and coronary athero-
sclerosis. Int Heart J 2014;55:197-203.
22. Mazurek T, Zhang L, Zalewski A, Mannion JD, Diehl JT, Arafat H, et al.
Human epicardial adipose tissue is a source of inflammatory mediators.
Circulation 2003;108:2460-6.
23. Sacks HS, Fain JN. Human epicardial adipose tissue: a review. Am Heart J
2007;153:907-17.
24. Rabkin SW. Epicardial fat: properties, function and relationship to obesity.
Obesity Rev 2007;8:253-61.
25. Shimabukuro M. Cardiac adiposity and global cardiometabolic risk: new
concept and clinical implication. Circ J 2009;73:27-34.
26. Hirata Y, Tabata M, Kurobe H, Motoki T, Akaike M, Nishio C, et al. Cor-
onary atherosclerosis is associated withmacrophage polarization in epicar-
dial adipose tissue. J Am Coll Cardiol 2011;58:248-55.
27. Hirata Y, Kurobe H, Akaike M, Chikugo F, Hori T, Bando Y, et al.
Enhanced inflammation in epicardial fat in patients with coronary artery
disease. Int Heart J 2011;52:139-42.
28. Manka D, Chatterjee TK, Stoll LL, Basford JE, Konaniah ES, Srinivasan R,
et al. Transplanted perivascular adipose tissue accelerates injury-induced
neointimal hyperplasia: role of monocyte chemoattractant protein-1.
Arterioscler Thromb Vasc Biol 2014;34:1723-30.
29. Sacks HS, Fain JN, Holman B, Cheema P, Chary A, Parks F, et al. Uncou-
pling protein-1 and related messenger ribonucleic acids in human epicar-
dial and other adipose tissues: epicardial fat functioning as brown fat. J Clin
Endocrinol Metab 2009;94:3611-5.
30. YokoyamaM, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y,
et al. Effects of eicosapentaenoic acid on major coronary events in hyper-
cholesterolaemic patients (JELIS): a randomised open-label, blinded
endpoint analysis. Lancet 2007;369:1090-8.
31. Wu FZ, Chou KJ, Huang YL, Wu MT. The relation of location-specific
epicardial adipose tissue thickness and obstructive coronary artery disease:
systemic review and meta-analysis of observational studies. BMC Cardio-
vasc Dis 2014;14:62.
32. Ohyama K, Matsumoto Y, Nishimiya K, Hao K, Tsuburaya R, Ota H, et al.
Increased coronary perivascular adipose tissue volume in patients with
vasospastic angina. Circ J 2016;80:1653-6.
20
30
40
50
60
70
80
90
2 4 6 8 10 12 14
AIG-EAT (mm)
LAD stenosis at acetylcholine infusion (%) 
R =0.47
P=.07
Supplemental Figure 1 Relationship between LAD stenosis at
ACh infusion and EAT-AIG thickness. There was a weak trend
between stenosis of the LAD and EAT-AIG thickness.
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Supplemental Figure 2 Differences among groups without
VSA, with LCA vasospasm alone, with both LCA and RCA vaso-
spasm, andwith RCA vasospasmalone. Among 17 patients with
infusion into both coronary arteries, there were nine patients
with LCA vasospasm alone, six patients with both LCA and
RCA vasospasm, and two patients with RCA vasospasm alone.
In these groups, EAT-AIG thickness was greater in three groups
than in the non-VSA group (6.1 vs 7.9 vs 8.2 vs 8.3 mm).
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